Search research articles
Contact Us
Filters
Showing results (1-10 of 132) with videos related to
Page
of 14
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
April 27, 2017
[Influence of smoking on pharmacokinetics of medication]
D M Burger
Pharmaceutisch Weekblad. Scientific Edition
|
October 16, 1992
Dideoxynucleoside therapy for HIV infection
D M Burger, J H Beijnen
Pharmacy World & Science : PWS
|
February 11, 1999
Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?
P P Koopmans, D M Burger
Annals of Internal Medicine
|
December 29, 1998
Pharmacokinetic interaction between saquinavir and cyclosporine
K Brinkman, F Huysmans, D M Burger
Pharmacy World & Science : PWS
|
March 24, 1995
Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents
D M Burger, P L Meenhorst, J H Beijnen
The Journal of Antimicrobial Chemotherapy
|
November 2, 2022
Outcomes of modern antiretroviral therapy in obese individuals living with HIV
L Zino, J Stalenhoef, A Colbers, et al.
HIV Medicine
|
June 21, 2023
GLP-1 agonists for people living with HIV and obesity, is there a potential?
L Zino, C J Tack, O Richel, et al.
AIDS (London, England)
|
April 16, 1998
Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients
K Brinkman, F Kroon, P W Hugen, et al.
The Netherlands Journal of Medicine
|
March 18, 2004
Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity
H J M ter Hofstede, D M Burger, P P Koopmans
Nederlands Tijdschrift Voor Geneeskunde
|
May 25, 1996
[Acanthamoeba keratitis]
C A Eggink, W Vaandrager, D M Burger, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 132) with videos related to
Sort By:
Page
of 14
Nederlands Tijdschrift Voor Geneeskunde
|
April 27, 2017
[Influence of smoking on pharmacokinetics of medication]
D M Burger
Pharmaceutisch Weekblad. Scientific Edition
|
October 16, 1992
Dideoxynucleoside therapy for HIV infection
D M Burger, J H Beijnen
Pharmacy World & Science : PWS
|
February 11, 1999
Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?
P P Koopmans, D M Burger
Annals of Internal Medicine
|
December 29, 1998
Pharmacokinetic interaction between saquinavir and cyclosporine
K Brinkman, F Huysmans, D M Burger
Pharmacy World & Science : PWS
|
March 24, 1995
Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents
D M Burger, P L Meenhorst, J H Beijnen
The Journal of Antimicrobial Chemotherapy
|
November 2, 2022
Outcomes of modern antiretroviral therapy in obese individuals living with HIV
L Zino, J Stalenhoef, A Colbers, et al.
HIV Medicine
|
June 21, 2023
GLP-1 agonists for people living with HIV and obesity, is there a potential?
L Zino, C J Tack, O Richel, et al.
AIDS (London, England)
|
April 16, 1998
Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients
K Brinkman, F Kroon, P W Hugen, et al.
The Netherlands Journal of Medicine
|
March 18, 2004
Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity
H J M ter Hofstede, D M Burger, P P Koopmans
Nederlands Tijdschrift Voor Geneeskunde
|
May 25, 1996
[Acanthamoeba keratitis]
C A Eggink, W Vaandrager, D M Burger, et al.
Page
of 14